Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer

• Daichi Fujimoto ,

  * E-mail: daichianzen@yahoo.co.jp

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Ryoji Kato,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Takeshi Morimoto,

  Affiliations Clinical Research Center, Kobe City Medical Center General Hospital, Kobe, Japan, Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan

  ⨯
• Ryoko Shimizu,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Yuki Sato,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Mariko Kogo,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Jiro Ito,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Shunsuke Teraoka,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Kazuma Nagata,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Atsushi Nakagawa,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Kojiro Otsuka,

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯
• Keisuke Tomii

  Affiliation Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan

  ⨯